米国では肥満と糖尿病の流行が続いている
A H Mokdad1, B A Bowman, E S Ford
1Data Management Division, National Immunization Program, Centers for Disease Control and Prevention, MS E62, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA. ahm1@cdc.gov
JAMA
|September 18, 2001
まとめ
肥満と糖尿病の罹患率は2000年までに米国の成人の間で増加した. 公衆衛生の介入は,全国的に食事と身体活動の改善に不可欠です.
科学分野:
- 公衆衛生は公衆衛生である.
- エピデミオロジー エピデミオロジー
- 予防医学は,予防的な医療です.
背景:
- 最近の報告によると,過去10年間で米国全土で肥満と糖尿病の割合が著しく上昇していることが示されています.
- これらの慢性疾患は,公衆衛生上の課題として増大しており,流行に関する最新データが必要となっている.
研究 の 目的:
- 2000年の米国成人の肥満と糖尿病の罹患率を測定する.
- 成人集団における体重管理戦略の活用を評価する.
主な方法:
- 2000年の全国電話調査である"行動リスク因子監視システム"のデータを活用した.
- 18歳以上184,450人の成人を含め,自己報告した体重,身長,および糖尿病の状態を収集しました.
- 体質指数 (BMI) を計算し,身体活動,食事習慣,体重管理に関するアドバイスを分析した.
主要な成果:
- 2000年,米国の成人の19.8%が肥満 (BMI ≥30 kg/m2),7.3%が糖尿病,2.9%が両方の疾患を患っていた.
- 流行の有意な変動は州によって観察され,ミシシッピは糖尿病/肥満で最高,アラスカ/コロラドは最低でした.
- 低レベルの身体活動 (55.2%不活動) と果物/野菜の消費不足 (24.4%がガイドラインを満たした) が一般的であった.
結論:
- この研究は,米国の成人の間で肥満と糖尿病の流行が増加していることを確認しています.
- 地域社会における身体活動の強化と食事のパターンの改善に焦点を当てた全国的な介入の緊急性を強調する.
さらに関連する動画
関連する概念動画
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...


